TCRyption

TCRyption Focuses on New Approaches to TCR-Based T Cell Therapy. The founders of TCRyption include visionary pioneers in T cell biology, such as Drs. Mark Davis and Tak Mak, co-discoverers of the T cell receptor, as well as Dr. Naoto Hirano and Dr. Pamela Ohashi, developers of the TCRypt platform.